Aim To investigate association of two LPIN1 gene variations with main traits of metabolic syndrome (MS) (waist circumference, body mass index, blood pressure, triglycerides, HDL-cholesterol and fasting glucose levels) in population from Bosnia and Herzegovina. Methods This study included 43 patients with metabolic syndrome and 43 healthy controls from General Hospital in Tešanj, Bosnia and Herzegovina. Subjects were genotyped for two LPIN1 gene variations (rs11693809: C>T and rs2716610: C>T) by real time PCR method. Results In control subjects LPIN1 polymorphism, rs2716610: C>T, was significantly associated with a lower body mass index (BMI) (p=0.008) and waist circumference (p=0.008). The second analyzed rs11693809: C>T polymorphism was associated with lower blood HbA1c levels (p=0.048) in a group of MS patients. Conclusion Results of our study suggest that rs2716610: C>T polymorphism of LPIN1 gene could have a protective effect against development of metabolic syndrome, while rs11693809: C>T might affect a glucose control in patients with MS.
Zhao J. 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 2004:1325–6.
2
Suviolahti E, Reue K, Cantor R, Phan J, Gentile M, Naukkarinen J, et al. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum Mol Genet 2006:377–86.
3
Loos R, Rankinen T, Perusse L, Tremblay A, Despres J, Bouchard C. Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity (Silver Spring) 2007:2723–32.
4
Cao H, Hegele R. Identification of single-nucleotide polymorphisms in the human LPIN1 gene. J Hum Genet 2002:370–2.
5
Fawcett K, Grimsey N, Loos R, Wheeler E, Daly A, Soos M, et al. Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. Populations. Diabetes 2008:2527–33.
6
Ong K, Leung R, Wong L, Cherny S, Sham P, Lam T, et al. Association of a polymorphism in the lipin 1 gene with systolic blood pressure in men. Am J Hypertens 2008:539–45.
7
Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A, et al. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 2008:209–17.
8
Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985:412–9.
9
Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988:1215.
10
Van Harmelen V, Ryden M, Sjolin E, Hoffstedt J. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res 2007:201–6.
11
Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001:978–89.
12
Bego T, Dujic T, Mlinar B, Semiz S, Malenica M, Prnjavorac B, et al. Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes. Med Glas Ljek Komore Zenicko-Doboj Kantona 2011:76–83.
13
Mlinar B, Ferk P, Pfeifer M, Gersak K, Marc J. Lipin 1 gene polymorphisms in polycystic ovary syndrome. Horm Metab Res 2011:427–32.
14
Forlani G, Bonito D, Mannucci P, Capaldo E, Genovese B, Orrasch S, et al. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest 2008:146–52.
15
Marchesini G, Avagnina S, Barantani E, Ciccarone A, Corica F, Dall’aglio E, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest 2005:333–9.
16
Zhang Y, Lu X, Hong J, Chao M, Gu W, Wang W, et al. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine 2010:181–7.
17
Lal S, Sukla Y, Singh A, Andriyas A, Lall M. Hyperuricemia, high serum urea and hypoproteinemia are the risk facror for diabetes. Asian Journal of Medical Sciences 2009:33–4.
18
Idonije B, Festus O, Oluba M. Plasma glucose, creatinine and urea levels in type 2 diabetic patients attending a Nigerian Teaching Hospital. Research Journal of Medical Sciences 2011:1–3.
19
Donkor J, Sariahmetoglu M, Dewald J, Brindley D, Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 2007:3450–7.
20
Ggt. n.d.
21
Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988:1595–607.
22
Defronzo R, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991:173–94.
23
Kaplan N. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989:1514–20.
24
Eckel R, Grundy S, Zimmet P. The metabolic syndrome. Lancet 2005:1415–28.
25
Grundy S. Metabolic syndrome pandemic. Arterioscler Thromb Vasc. Biol 2008:629–36.
26
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute. Circulation 2009:1640–5.
27
Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al. Diagnosis and management of the metabolic syndrome: an. Circulation 2005:2735–52.
28
Bilirubin. n.d.
29
Rankinen T, Zuberi A, Chagnon Y, Weisnagel S, Argyropoulos G, Walts B, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006:529–644.
30
Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 2001:121–4.
31
Peterfy M, Phan J, Reue K. Alternatively spliced lipin isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem 2005:32883–9.
32
Phan J, Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab 2005:73–83.
33
Reue K, Dwyer J. Lipin proteins and metabolic homeostasis. J Lipid Res 2009:109–14.
34
Donkor J, Sparks L, Xie H, Smith S, Reue K. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J Clin Endocrinol Metab 2008:233–9.
35
Croce M, Eagon J, Lariviere L, Korenblat K, Klein S, Finck B. Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes 2007:2395–9.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
